Carbazole scaffolds in cancer therapy: a review from 2012 to 2018
Résumé
For over half a century, the carbazole skeleton has been the key structural motif of many biologically active compounds including natural and synthetic products. Carbazoles have taken an important part in all the existing anti-cancer drugs because of their discovery from a large variety of organisms, including bacteria, fungi, plants, and animals. In this article, we specifically explored the literature from 2012 to 2018 on the anti-tumour activities reported to carbazole derivatives and we have critically collected the most significant data. The most described carbazole anti-tumour agents were classified according to their structure, starting from the tricyclic-carbazole motif to fused tetra-, penta-, hexa-and heptacyclic carba-zoles. To date, three derivatives are available on the market and approved in cancer therapy.
Fichier principal
Carbazole scaffolds in cancer therapy a review from 2012 to 2018-MLB.pdf (6.54 Mo)
Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...